View our archive of investor presentations, annual and interim reports from 4D pharma plc (AIM: DDDD)


Management presentation, May 2020

Developing Science, Delivering Therapies


R&D Webinar Clinical Update: Oncology & COVID-19, 5 June 2020

4D's Chairman, CEO and CSO host a virtual R&D event providing an update on the Company's clinical programmes in oncology and COVID-19, including a Q&A with covering analysts

You can download the presentation slides and a transcript of the audio

Proactive Investors interview with 4D CEO Duncan Peyton, 29 May 2020

Watch Proactive Investors Andrew Scott's interview with 4D's CEO, discussing recent progress in the clinic in oncology and IBS, our Phase II trial in COVID-19, and more


COVID-19: MRx-4DP0004, an oral immunomodulatory therapeutic

A summary of the scientific rationale supporting our LBP, MRx-4DP0004, as a therapeutic for patients hospitalised with COVID-19, to prevent or reduce the hyper-inflammatory response associated with more severe disease


Chardan's 2nd Annual Microbiome Medicine Summit, 17 March 2020

CEO Duncan Peyton and CSO Alex Stevenson provide an update on clinical progress in oncology, and timelines and catalysts for 2020



View RNS announcements

Subscribe to RNS email alerts


Date 2020 Jun 05
Title Annual report for the year ended 31 December 2019
Document (3,289KB)
Link
Date 2019 Sep 30
Title Interim results for the period ended 30 June 2019
Document (629KB)
Link
Date 2019 May 28
Title Annual report for the year ended 31 December 2018
Document (4,255KB)
Link
Date 2018 Sep 28
Title Interim results for the period ended 30 June 2018
Document (269KB)
Link visit
Date 2018 Apr 25
Title Annual report for the year ended 31 December 2017
Document (1,369KB)
Link
Date 2017 Sep 27
Title Interim results for the period ended 30 June 2017
Document (2,820KB)
Link
Date 2017 May 02
Title Annual report for the year ended 31 December 2016
Document (3,262KB)
Link
Date 2016 Sep 30
Title Interim results for the period ended 30 June 2016
Document
Link visit
Date 2016 May 06
Title Annual report for the year ended 31 December 2015
Document (771KB)
Link
Date 2015 Sep 29
Title Interim results for the period ended 30 June 2015
Document (429KB)
Link
Date 2015 May 06
Title Annual Report for the year ended 31 December 2014
Document (659KB)
Link
Date 2014 Sep 23
Title Interim results for the period ended 30 June 2014
Document
Link visit

For any enquiries please contact ir@4dpharmaplc.com

BACK TO TOP